Protein Aggregation and Polyasparagine-Mediated Cellular Toxicity in Saccharomyces cerevisiae

被引:22
作者
Peters, Theodore W. [1 ]
Huang, Mingxia [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA
关键词
polyasparagine; polyglutamine; protein aggregation; HSP104; RNQ1;
D O I
10.4161/pri.1.2.4630
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is well established that protein aggregation is associated with many neurodegenerative disorders including polyglutamine diseases, but a mechanistic understanding of the role of protein aggregates in the disease pathogenesis remains elusive. Previously thought to be the cause of cellular toxicity such as cellular dysfunction and cell death, protein aggregation is now proposed to serve a protective role by sequestering toxic oligomers from interfering with essential physiological processes. To investigate the relationship between protein aggregation and cellular toxicity, we have characterized and compared the effects of two GFP-fusion proteins that form aggregates in Saccharomyces cerevisiae, one with a polyasparagine repeat (GFP(N104)) and one without (GFPC). Although both proteins can form microscopically visible GFP-positive aggregates, only the GFP(N104)-containing aggregates exhibit morphological and biochemical characteristics that resemble the aggregates formed by mutant huntingtin in yeast cells. Formation of both the GFPC and GFPN104 aggregates depends on microtubules, while only the GFPN104 aggregate requires the chaperone Hsp 104 and the prion Rnq 1 and is resistant to SDS. Although no microscopically visible GFP(N104) aggregates were observed in the hsp 104 Delta and rnq 1 Delta mutant cells, SDS-insoluble aggregates can still be detected by the filter trap assay. These observations argue that the GFP(N104)-containing aggregates can exist in at least two distinct states in vivo. We also show that a nucleus-targeted GFP(N104) interferes with transcription from two SAGA-dependant promoters and results in a decrease in cell viability. Overall, the results imply that the GFP(N104) protein behaves similarly to the mutant huntingtin in yeast cells and provides a new model for investigating the interplay between protein aggregates and the associated phenotypes.
引用
收藏
页码:144 / 153
页数:10
相关论文
共 77 条
[1]   The other trinucleotide repeat: polyalanine expansion disorders [J].
Albrecht, A ;
Mundlos, S .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (03) :285-293
[2]   Cotransport of the heterodimeric small subunit of the Saccharomyces cerevisiae ribonucleotide reductase between the nucleus and the cytoplasm [J].
An, Xinxiang ;
Zhang, Zhen ;
Yang, Kui ;
Huang, Mingxia .
GENETICS, 2006, 173 (01) :63-73
[3]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[4]   Differential requirement of SAGA components for recruitment of TATA-box-binding protein to promoters in vivo [J].
Bhaumik, SR ;
Green, MR .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (21) :7365-7371
[5]  
Burke D., 2000, Methods in Yeast Genetics Plainview, NY, V2000
[6]   Accumulation of insoluble α-synuclein in dementia with Lewy bodies [J].
Campbell, BCV ;
Li, QX ;
Culvenor, JG ;
Jäkälä, P ;
Cappai, R ;
Beyreuther, K ;
Masters, CL ;
McLean, CA .
NEUROBIOLOGY OF DISEASE, 2000, 7 (03) :192-200
[7]   Nuclear aggregation of huntingtin is not prevented by deletion of chaperone Hsp104 [J].
Cao, F ;
Levine, JJ ;
Li, SH ;
Li, XJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2001, 1537 (02) :158-166
[8]   Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease [J].
Carmichael, J ;
Chatellier, J ;
Woolfson, A ;
Milstein, C ;
Fersht, AR ;
Rubinsztein, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9701-9705
[9]   Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation [J].
Chui, DH ;
Tanahashi, H ;
Ozawa, K ;
Ikeda, S ;
Checler, F ;
Ueda, O ;
Suzuki, H ;
Araki, W ;
Inoue, H ;
Shirotani, K ;
Takahashi, K ;
Gallyas, F ;
Tabira, T .
NATURE MEDICINE, 1999, 5 (05) :560-564
[10]   Pathways to parkinsonism [J].
Cookson, MR .
NEURON, 2003, 37 (01) :7-10